New recommendations to strengthen supply chains of critical medicines
https://www.ema.europa.eu/en/news/new-recommendations-strengthen-supply-chains-critical-medicines
Meeting highlights from the PRAC 8-11 April 2024
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-april-2024
Regulatory information – adjusted fees for applications to EMA from 1 April 2024
https://www.ema.europa.eu/en/news/regulatory-information-adjusted-fees-applications-ema-1-april-2024
Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials – Scientific guideline
https://www.ema.europa.eu/en/guideline-quality-non-clinical-clinical-requirements-investigational-advanced-therapy-medicinal-products-clinical-trials-scientific-guideline
Accelerating stakeholder collaboration to enhance the clinical trials environment in the EU
https://www.ema.europa.eu/en/news/accelerating-stakeholder-collaboration-enhance-clinical-trials-environment-eu
When you’re pregnant, it’s (always) important to take the right kind of medicine!
https://ansm.sante.fr/actualites/enceinte-les-medicaments-cest-toujours-pas-nimporte-comment
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 March 2024
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-mars-2024-4-7-mars
